Exchange: NASDAQ·Updated 02:42 PM EDT

RNLX Renalytix AI Plc - ADR

$4.49
$0.085
(1.93%)
Today
Reported EarningsNov 20
Mkt Cap$39.2M
Vol8,500.00

About RNLX

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
49

Neutral Sentiment

How do you feel about RNLX?

Advertisement|Remove ads.